Integrating PrEP Into Mobile Addiction and Primary Care Services (MAPS)
Trial Snapshot
- Phase
- Phase 4
- Status
- Completed
- Sponsor
- Enrollment
- 7
- Locations
- 1
- Primary Endpoint
- Enrollment
Study Overview
Brief Summary
For this study the investigators aim to see if giving participants an oral HIV prevention medication on a medical van, is a good option of care for individuals who inject drugs and/or are sexually active and therefore at a higher risk of contracting HIV.
Detailed Description
The purpose of this study is to evaluate a pilot program that provides Pre-Exposure Prophylaxis (PrEP) for people who use drugs (PWUD) and are at risk for contracting HIV. Given the ongoing overdose crisis and the risk of HIV among PWUD, this study aims to assess weather offering oral PrEP on a Medical Mobile Unit (MMU) is a viable strategy for preventing HIV transmission in high-risk populations. The other goal of this study is to assess community perceptions of PrEP and perceived HIV risk among Syringe Service Program (SSP) clients visiting a MMU.
Study Design
- Study Type
- Interventional
- Allocation
- Na
- Intervention Model
- Single Group
- Primary Purpose
- Prevention
- Masking
- None
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- •18 years or older, active drug injection user and/or sexually active, referred from the Syringe Service Program
Exclusion Criteria
- •positive HIV status
Arms & Interventions
PrEP
All eligible participants will be given oral PrEP pills to reduce their risk for contracting HIV.
Intervention: Pre-Exposure Prophylaxis (PrEP) (Drug)
Outcomes
Primary Outcomes
Enrollment
Time Frame: Baseline
Number of participants utilizing medical mobile unit during study duration who are eligible for PrEP
Negative HIV Status
Time Frame: up to 3 months
Number of participants who remain HIV negative at 3 months (Measured via negative HIV test at 3 months
PrEP Consultation
Time Frame: up to 6 months
Number of participants who agree to PrEP consultation
PrEP Initiation
Time Frame: up to 6 months
Number of participants who complete PrEP consultation and start PrEP
Retention
Time Frame: up to 6 months
Number of participants who come back for 3 month and 6 month visit
Follow Through
Time Frame: up to 6 months
Number of participants who pick up PrEP medication
Negative HIV Status at 6 months
Time Frame: up to 6 months
Number of participants who remain HIV negative at 6 months (Measured via negative HIV test at 6 months)
Secondary Outcomes
No secondary outcomes reported